TY  - GEN
AU  - Erber,Ramona
AU  - Gluz,Oleg
AU  - Brünner,Nils
AU  - Kreipe,Hans Heinrich
AU  - Pelz,Enrico
AU  - Kates,Ronald
AU  - Bartels,Annette
AU  - Huober,Jens
AU  - Mohrmann,Svjetlana
AU  - Moustafa,Zehra
AU  - Liedtke,Cornelia
AU  - Möbus,Volker
AU  - Augustin,Doris
AU  - Thomssen,Christoph
AU  - Jänicke,Fritz
AU  - Kiechle,Marion
AU  - Kuhn,Walther
AU  - Nitz,Ulrike
AU  - Harbeck,Nadia
AU  - Hartmann,Arndt
TI  - Predictive role of HER2/neu, topoisomerase-II-alpha, and tissue inhibitor of metalloproteinases (TIMP-1) for response to adjuvant taxane-based chemotherapy in patients with intermediate-risk breast cancer: results from the WSG-AGO EC-Doc trial
SN  - 1573-7217
PY  - 2015///1204
KW  - Antigens, Neoplasm
KW  - genetics
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Biomarkers, Tumor
KW  - metabolism
KW  - Breast Neoplasms
KW  - drug therapy
KW  - Chemotherapy, Adjuvant
KW  - DNA Topoisomerases, Type II
KW  - DNA-Binding Proteins
KW  - Disease-Free Survival
KW  - Female
KW  - Humans
KW  - Kaplan-Meier Estimate
KW  - Middle Aged
KW  - Multivariate Analysis
KW  - Prognosis
KW  - Proportional Hazards Models
KW  - Receptor, ErbB-2
KW  - Risk
KW  - Taxoids
KW  - administration & dosage
KW  - Tissue Inhibitor of Metalloproteinase-1
KW  - Treatment Outcome
N1  - Publication Type: Journal Article; Randomized Controlled Trial
UR  - https://doi.org/10.1007/s10549-015-3310-x
ER  -